HPV AND PAP TESTING MARKET ANALYSIS

HPV and Pap Testing Market, by Test Type (HPV Test and Pap test), by Application (Cervical Cancer and Vaginal Cancer), by End User (Hospitals, Diagnostic Centers, Home Care Settings, and Others), and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Dec 2024
Code : CMI1733
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Leading Companies

Competitive Landscape

Key players operating in the global HPV testing and Pap test market include Qiagen N.V., Abbott Laboratories, Becton, Dickinson & Company, Hologic, Inc., Quest Diagnostics, Femasys, Inc., Roche Diagnostics, Arbor Vita Corporation, Onco Health Corporation, Seegene, Inc., and others. Market players are focused towards providing efficient and accurate tests at low prices to sustain their presence in the market. For instance, in April 2019, Hologic, Inc. received European CE Mark for ThinPrep Genesis processor in Europe. ThinPrep Genesis processor is an automated cytology slide and molecular sample system which allows for accurate and reliable results with increased operational efficiency.

Similarly in February 2018, Becton, Dickinson and Company received FDA approval for the BD Onclarity HPV assay, which detects and identifies HPV genotypes that put women at high risk for cervical cancer.